"Albumin-Bound Paclitaxel" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
An injectable formulation of albumin-bound paclitaxel NANOPARTICLES.
| Descriptor ID |
D000068196
|
| MeSH Number(s) |
D02.455.426.392.368.242.888.777.500 D02.455.849.291.850.777.500 D12.776.034.073
|
| Concept/Terms |
Albumin-Bound Paclitaxel- Albumin-Bound Paclitaxel
- Albumin Bound Paclitaxel
- Paclitaxel, Albumin-Bound
- Protein-Bound Paclitaxel
- Paclitaxel, Protein-Bound
- Protein Bound Paclitaxel
|
Below are MeSH descriptors whose meaning is more general than "Albumin-Bound Paclitaxel".
Below are MeSH descriptors whose meaning is more specific than "Albumin-Bound Paclitaxel".
This graph shows the total number of publications written about "Albumin-Bound Paclitaxel" by people in this website by year, and whether "Albumin-Bound Paclitaxel" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2007 | 0 | 1 | 1 |
| 2010 | 0 | 1 | 1 |
| 2011 | 0 | 2 | 2 |
| 2013 | 0 | 1 | 1 |
| 2015 | 0 | 1 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Albumin-Bound Paclitaxel" by people in Profiles.
-
Abu-Khalaf MM, Baumgart MA, Gettinger SN, Doddamane I, Tuck DP, Hou S, Chen N, Sullivan C, Lezon-Geyda K, Zelterman D, Hatzis C, Deshpande H, Digiovanna MP, Azodi M, Schwartz PE, Harris LN. Phase 1b study of the mammalian target of rapamycin inhibitor sirolimus in combination with nanoparticle albumin-bound paclitaxel in patients with advanced solid tumors. Cancer. 2015 Jun 01; 121(11):1817-26.
-
Rahimy E, Sarraf D. Cystoid macular edema secondary to nanoparticle albumin-bound Paclitaxel therapy. Ophthalmic Surg Lasers Imaging Retina. 2013 Mar-Apr; 44(2):187-9.
-
McKiernan JM, Barlow LJ, Laudano MA, Mann MJ, Petrylak DP, Benson MC. A phase I trial of intravesical nanoparticle albumin-bound paclitaxel in the treatment of bacillus Calmette-Gu?rin refractory nonmuscle invasive bladder cancer. J Urol. 2011 Aug; 186(2):448-51.
-
Baskin DE, Garg SJ. Abraxane-induced cystoid macular edema refractory to concomitant intravenous bevacizumab. Can J Ophthalmol. 2011 Apr; 46(2):200-1.
-
Robidoux A, Buzdar AU, Quinaux E, Jacobs S, Rastogi P, Fourchotte V, Younan RJ, Pajon ER, Shalaby IA, Desai AM, Fehrenbacher L, Geyer CE, Mamounas EP, Wolmark N. A phase II neoadjuvant trial of sequential nanoparticle albumin-bound paclitaxel followed by 5-fluorouracil/epirubicin/cyclophosphamide in locally advanced breast cancer. Clin Breast Cancer. 2010 Feb; 10(1):81-6.
-
Stinchcombe TE, Socinski MA, Walko CM, O'Neil BH, Collichio FA, Ivanova A, Mu H, Hawkins MJ, Goldberg RM, Lindley C, Dees EC. Phase I and pharmacokinetic trial of carboplatin and albumin-bound paclitaxel, ABI-007 (Abraxane) on three treatment schedules in patients with solid tumors. Cancer Chemother Pharmacol. 2007 Oct; 60(5):759-66.